I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Rordorf, Tamara
44
results:
Search for persons
X
Format
Online (44)
Mediatypes
Articles (Online) (22)
OpenAccess-fulltext (22)
Sorted by: Relevance
Sorted by: Year
?
1
Long-term Outcomes with Nivolumab as First-line Treatment i..:
Gillison, Maura L
;
Blumenschein Jr, George
;
Fayette, Jerome
...
The Oncologist. 27 (2022) 2 - p. e194-e198 , 2022
Link:
https://doi.org/10.1093/..
?
2
Pembrolizumab alone or with chemotherapy for recurrent or m..:
Rischin, Danny
;
Harrington, Kevin J.
;
Greil, Richard
...
Oral Oncology. 128 (2022) - p. 105815 , 2022
Link:
https://doi.org/10.1016/..
?
3
SalvGlandDx – a comprehensive salivary gland neoplasm speci..:
Freiberger, Sandra N.
;
Brada, Muriel
;
Fritz, Christine
...
Neoplasia. 23 (2021) 5 - p. 473-487 , 2021
Link:
https://doi.org/10.1016/..
?
4
IL-36γ drives skin toxicity induced by EGFR/MEK inhibition ..:
Satoh, Takashi K.
;
Mellett, Mark
;
Meier-Schiesser, Barbara
...
Journal of Clinical Investigation. 130 (2020) 3 - p. 1417-1430 , 2020
Link:
https://doi.org/10.1172/..
?
5
Consolidation cetuximab after concurrent triplet radiochemo..:
Riesterer, Oliver
;
Pruschy, Martin
;
Bender, Sabine
...
Radiotherapy and Oncology. 150 (2020) - p. 62-69 , 2020
Link:
https://doi.org/10.1016/..
?
6
Pembrolizumab alone or with chemotherapy versus cetuximab w..:
Burtness, Barbara
;
Harrington, Kevin J
;
Greil, Richard
...
The Lancet. 394 (2019) 10212 - p. 1915-1928 , 2019
Link:
https://doi.org/10.1016/..
?
7
Sequential somatic mutations upon secondary anti-HER2 treat..:
Nordmann, Thierry M.
;
Messerli-Odermatt, Olivia
;
Meier, Larissa
...
Oncotarget. 10 (2019) 62 - p. 6647-6650 , 2019
Link:
https://doi.org/10.18632..
?
8
Nivolumab vs investigator's choice in recurrent or metastat..:
Ferris, Robert L.
;
Blumenschein Jr., George
;
Fayette, Jerome
...
Oral Oncology. 81 (2018) - p. 45-51 , 2018
Link:
https://doi.org/10.1016/..
?
9
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivol..:
Gillison, Maura L.
;
Blumenschein Jr., George
;
Fayette, Jerome
...
The Oncologist. 23 (2018) 9 - p. 1079-1082 , 2018
Link:
https://doi.org/10.1634/..
?
10
18FDG-PET-CT identifies histopathological non-responders af..:
Schneider, Paul M.
;
Eshmuminov, Dilmurodjon
;
Rordorf, Tamara
...
BMC Cancer. 18 (2018) 1 - p. , 2018
Link:
https://doi.org/10.1186/..
?
11
Denosumab as a Treatment Alternative for Central Giant Cell..:
Bredell, Marius
;
Rordorf, Tamara
;
Kroiss, Sabine
...
Journal of Oral and Maxillofacial Surgery. 76 (2018) 4 - p. 775-784 , 2018
Link:
https://doi.org/10.1016/..
?
12
Neuer Therapieansatz mit Denosumab bei Riesenzellgranulomen..:
Rostetter, Claudio
;
Rordorf, Tamara
;
Essig, Harald
...
SWISS DENTAL JOURNAL SSO – Science and Clinical Topics. 127 (2017) 6 - p. 520-521 , 2017
Link:
https://doi.org/10.61872..
?
13
SAKK 24/09: safety and tolerability of bevacizumab plus pac..:
on behalf of the Swiss Group for Clinical Cancer Research (SAKK)
;
Rochlitz, Christoph
;
Bigler, Martin
...
BMC Cancer. 16 (2016) 1 - p. , 2016
Link:
https://doi.org/10.1186/..
?
14
IMRT/VMAT for malignancies in the head-and-neck region: Out..:
Brown, Michelle L.
;
Glanzmann, Christoph
;
Huber, Gerhard
...
Strahlentherapie und Onkologie. 192 (2016) 8 - p. 526-536 , 2016
Link:
https://doi.org/10.1007/..
?
15
Expression of CK19 is an independent predictor of negative ..:
Ernst, Jutta
;
Ikenberg, Kristian
;
Apel, Barbara
...
Oncotarget. 7 (2016) 46 - p. 76151-76158 , 2016
Link:
https://doi.org/10.18632..
1-15